Annual Cash & Cash Equivalents
$4.28 M
-$225.00 K-4.99%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual cash & cash equivalents is $4.28 million, with the most recent change of -$225.00 thousand (-4.99%) on December 31, 2023.
- During the last 3 years, HBIO annual cash & cash equivalents has fallen by -$4.03 million (-48.50%).
- HBIO annual cash & cash equivalents is now -88.04% below its all-time high of $35.82 million, reached on December 31, 2000.
Performance
HBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.57 M
+$521.00 K+12.87%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly cash and cash equivalents is $4.57 million, with the most recent change of +$521.00 thousand (+12.87%) on September 30, 2024.
- Over the past year, HBIO quarterly cash and cash equivalents has dropped by -$771.00 thousand (-14.44%).
- HBIO quarterly cash and cash equivalents is now -89.22% below its all-time high of $42.39 million, reached on March 31, 2001.
Performance
HBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HBIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.0% | -14.4% |
| 3 y3 years | -48.5% | -17.6% |
| 5 y5 years | -47.6% | -33.3% |
HBIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.2% | at low | -41.6% | +20.6% |
| 5 y | 5-year | -48.6% | at low | -45.2% | +73.8% |
| alltime | all time | -88.0% | +347.5% | -89.2% | +73.8% |
Harvard Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.57 M(+12.9%) |
| Jun 2024 | - | $4.05 M(-4.9%) |
| Mar 2024 | - | $4.25 M(-0.7%) |
| Dec 2023 | $4.28 M(-5.0%) | $4.28 M(-19.8%) |
| Sep 2023 | - | $5.34 M(+23.5%) |
| Jun 2023 | - | $4.32 M(+14.1%) |
| Mar 2023 | - | $3.79 M(-15.9%) |
| Dec 2022 | $4.51 M(-42.4%) | $4.51 M(-12.4%) |
| Sep 2022 | - | $5.14 M(+20.8%) |
| Jun 2022 | - | $4.26 M(-21.6%) |
| Mar 2022 | - | $5.43 M(-30.5%) |
| Dec 2021 | $7.82 M(-6.0%) | $7.82 M(+41.0%) |
| Sep 2021 | - | $5.55 M(-11.0%) |
| Jun 2021 | - | $6.24 M(+7.3%) |
| Mar 2021 | - | $5.82 M(-30.1%) |
| Dec 2020 | $8.32 M(-0.2%) | $8.32 M(+196.4%) |
| Sep 2020 | - | $2.81 M(+6.7%) |
| Jun 2020 | - | $2.63 M(-55.3%) |
| Mar 2020 | - | $5.88 M(-29.4%) |
| Dec 2019 | $8.34 M(+2.0%) | $8.34 M(+21.8%) |
| Sep 2019 | - | $6.84 M(+38.7%) |
| Jun 2019 | - | $4.93 M(-1.9%) |
| Mar 2019 | - | $5.03 M(-38.5%) |
| Dec 2018 | $8.17 M(+57.4%) | $8.17 M(+22.7%) |
| Sep 2018 | - | $6.66 M(+18.4%) |
| Jun 2018 | - | $5.62 M(-6.1%) |
| Mar 2018 | - | $5.99 M(+15.4%) |
| Dec 2017 | $5.19 M(-7.2%) | $5.19 M(-11.0%) |
| Sep 2017 | - | $5.84 M(+23.5%) |
| Jun 2017 | - | $4.72 M(+2.7%) |
| Mar 2017 | - | $4.60 M(-17.8%) |
| Dec 2016 | $5.60 M(-17.0%) | $5.60 M(+4.7%) |
| Sep 2016 | - | $5.34 M(+47.2%) |
| Jun 2016 | - | $3.63 M(-13.0%) |
| Mar 2016 | - | $4.17 M(-38.1%) |
| Dec 2015 | $6.74 M(-52.3%) | $6.74 M(+10.7%) |
| Sep 2015 | - | $6.09 M(-17.7%) |
| Jun 2015 | - | $7.40 M(-7.8%) |
| Mar 2015 | - | $8.03 M(-43.2%) |
| Dec 2014 | $14.13 M(-45.2%) | $14.13 M(-47.1%) |
| Sep 2014 | - | $26.73 M(+1.1%) |
| Jun 2014 | - | $26.43 M(+2.3%) |
| Mar 2014 | - | $25.84 M(+0.3%) |
| Dec 2013 | $25.77 M(+24.6%) | $25.77 M(-30.2%) |
| Sep 2013 | - | $36.93 M(+8.3%) |
| Jun 2013 | - | $34.10 M(+43.6%) |
| Mar 2013 | - | $23.75 M(+14.8%) |
| Dec 2012 | $20.68 M | $20.68 M(+2.0%) |
| Sep 2012 | - | $20.29 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $18.66 M(+8.2%) |
| Mar 2012 | - | $17.24 M(-3.8%) |
| Dec 2011 | $17.92 M(-9.1%) | $17.92 M(+10.3%) |
| Sep 2011 | - | $16.24 M(-25.3%) |
| Jun 2011 | - | $21.75 M(+8.3%) |
| Mar 2011 | - | $20.09 M(+1.9%) |
| Dec 2010 | $19.70 M(+18.8%) | $19.70 M(+14.4%) |
| Sep 2010 | - | $17.22 M(+9.5%) |
| Jun 2010 | - | $15.72 M(-7.8%) |
| Mar 2010 | - | $17.04 M(+2.7%) |
| Dec 2009 | $16.59 M(+21.1%) | $16.59 M(+13.3%) |
| Sep 2009 | - | $14.64 M(-12.8%) |
| Jun 2009 | - | $16.80 M(+5.8%) |
| Mar 2009 | - | $15.88 M(+16.0%) |
| Dec 2008 | $13.70 M(-23.4%) | $13.70 M(+17.5%) |
| Sep 2008 | - | $11.66 M(-15.5%) |
| Jun 2008 | - | $13.80 M(+10.8%) |
| Mar 2008 | - | $12.46 M(-30.4%) |
| Dec 2007 | $17.89 M(+91.2%) | $17.89 M(+29.7%) |
| Sep 2007 | - | $13.80 M(+53.8%) |
| Jun 2007 | - | $8.97 M(+4.2%) |
| Mar 2007 | - | $8.61 M(-8.0%) |
| Dec 2006 | $9.36 M(+22.6%) | $9.36 M(+32.8%) |
| Sep 2006 | - | $7.05 M(-14.5%) |
| Jun 2006 | - | $8.24 M(-16.3%) |
| Mar 2006 | - | $9.85 M(+29.0%) |
| Dec 2005 | $7.63 M(-45.0%) | $7.63 M(-32.3%) |
| Sep 2005 | - | $11.27 M(-14.9%) |
| Jun 2005 | - | $13.24 M(+7.1%) |
| Mar 2005 | - | $12.37 M(-10.8%) |
| Dec 2004 | $13.87 M(+68.6%) | $13.87 M(+19.6%) |
| Sep 2004 | - | $11.59 M(+10.3%) |
| Jun 2004 | - | $10.52 M(+7.6%) |
| Mar 2004 | - | $9.77 M(+18.8%) |
| Dec 2003 | $8.22 M(-46.3%) | $8.22 M(+8.5%) |
| Sep 2003 | - | $7.58 M(-17.5%) |
| Jun 2003 | - | $9.19 M(-1.4%) |
| Mar 2003 | - | $9.32 M(-39.1%) |
| Dec 2002 | $15.31 M(-47.9%) | $15.31 M(-42.1%) |
| Sep 2002 | - | $26.46 M(-2.1%) |
| Jun 2002 | - | $27.02 M(-10.0%) |
| Mar 2002 | - | $30.04 M(+2.2%) |
| Dec 2001 | $29.39 M(-18.0%) | $29.39 M(-2.6%) |
| Sep 2001 | - | $30.16 M(-3.3%) |
| Jun 2001 | - | $31.18 M(-26.4%) |
| Mar 2001 | - | $42.39 M(+18.3%) |
| Dec 2000 | $35.82 M(+1394.8%) | $35.82 M |
| Dec 1999 | $2.40 M(+150.4%) | - |
| Dec 1998 | $957.00 K | - |
FAQ
- What is Harvard Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Harvard Bioscience?
- What is Harvard Bioscience annual cash & cash equivalents year-on-year change?
- What is Harvard Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Harvard Bioscience?
- What is Harvard Bioscience quarterly cash and cash equivalents year-on-year change?
What is Harvard Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of HBIO is $4.28 M
What is the all time high annual cash & cash equivalents for Harvard Bioscience?
Harvard Bioscience all-time high annual cash & cash equivalents is $35.82 M
What is Harvard Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, HBIO annual cash & cash equivalents has changed by -$225.00 K (-4.99%)
What is Harvard Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HBIO is $4.57 M
What is the all time high quarterly cash and cash equivalents for Harvard Bioscience?
Harvard Bioscience all-time high quarterly cash and cash equivalents is $42.39 M
What is Harvard Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, HBIO quarterly cash and cash equivalents has changed by -$771.00 K (-14.44%)